Highlander Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Highlander Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$47.4K	Hold	500	–	–	0.02%	402
2023 Q4	$44.6K	Hold	500	–	–	0.02%	408
2023 Q3	$37K	Buy	500 +200	+67%	+$16K	0.01%	415
2023 Q2	$25K	Hold	300	–	–	0.01%	399
2023 Q1	$23K	Hold	300	–	–	0.01%	407
2022 Q4	$25K	Hold	300	–	–	0.01%	368
2022 Q3	$24K	Hold	300	–	–	0.01%	360
2022 Q2	$22K	Hold	300	–	–	0.01%	391
2022 Q1	$27K	Hold	300	–	–	0.01%	367
2021 Q4	$34K	Hold	300	–	–	0.02%	341
2021 Q3	$38K	Hold	300	–	–	0.02%	315
2021 Q2	$41K	Hold	300	–	–	0.02%	318
2021 Q1	$41K	Hold	300	–	–	0.02%	311
2020 Q4	$42K	Hold	300	–	–	0.02%	309
2020 Q3	$33K	Hold	300	–	–	0.02%	337
2020 Q2	$34K	Hold	300	–	–	0.02%	331
2020 Q1	$23K	Hold	300	–	–	0.02%	381
2019 Q4	$29K	Hold	300	–	–	0.02%	375
2019 Q3	$23K	Hold	300	–	–	0.01%	409
2019 Q2	$26K	Hold	300	–	–	0.02%	417
2019 Q1	$27K	Hold	300	–	–	0.02%	411
2018 Q4	$22K	Hold	300	–	–	0.01%	429
2018 Q3	$29K	Hold	300	–	–	0.02%	432
2018 Q2	$29K	Hold	300	–	–	0.02%	433
2018 Q1	$27K	Hold	300	–	–	0.02%	439
2017 Q4	$25K	Hold	300	–	–	0.02%	459
2017 Q3	$26K	Hold	300	–	–	0.02%	454
2017 Q2	$23K	Hold	300	–	–	0.02%	487
2017 Q1	$21K	Buy	+300	New	+$20.1K	0.02%	501

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Highlander Capital Management's XBI Position: Q1 2024 in Review

Highlander Capital Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2024 at 500 shares worth $47.4K. The position accounts for 0.02% of the portfolio, ranked #402.

Highlander Capital Management first reported a position in XBI in Q1 2017 and has held it in 29 quarters since. 780 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Highlander Capital Management held 500 shares of State Street SPDR S&P Biotech ETF worth $47.4K as of Q1 2024.
Highlander Capital Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2024.
State Street SPDR S&P Biotech ETF made up 0.02% of Highlander Capital Management's portfolio in Q1 2024, its #402 holding.
Highlander Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 29 quarters since.
780 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.